Earnings
EGRX
44.27
-0.09%
-0.04
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
103.16M
--
--
51.12M
--
--
0.00
--
8.07M
--
3.72M
--
166.06M
2.08M
--
--
--
39.74M
12.92M
--
32.39M
87.13M
253.19M
--
6.27M
0.00
--
--
--
--
--
23.82M
--
--
--
--
38.09M
25.14M
--
--
--
3.96M
29.09M
67.18M
17.00K
305.40M
84.49M
-203.90M
--
--
186.01M
186.01M
253.19M
FY 2019-12-31
109.78M
--
--
48.00M
--
--
0.00
--
6.57M
--
15.10M
--
179.45M
5.92M
--
--
--
39.74M
15.58M
--
13.86M
75.11M
254.55M
--
5.46M
0.00
--
--
--
--
--
28.36M
--
--
--
--
38.82M
33.56M
--
--
--
3.00M
36.56M
75.38M
17.00K
278.52M
72.50M
-171.86M
--
--
179.17M
179.17M
254.55M
FY 2018-12-31
78.79M
--
--
66.49M
--
--
0.00
--
8.30M
--
10.26M
--
163.84M
2.40M
--
--
--
39.74M
18.10M
--
14.52M
74.76M
238.60M
--
9.92M
0.00
--
--
--
--
--
23.52M
--
--
--
--
39.69M
38.16M
--
--
--
0.00
38.16M
77.84M
17.00K
256.46M
58.19M
-153.90M
--
--
160.76M
160.76M
238.60M
FY 2017-12-31
114.66M
--
--
53.82M
--
--
0.00
--
5.12M
--
15.10M
--
188.70M
6.82M
--
--
--
39.74M
23.32M
--
11.48M
81.36M
270.06M
--
27.04M
0.00
--
--
--
--
--
15.39M
--
--
--
--
47.30M
42.91M
--
--
--
709.00K
43.61M
90.92M
16.00K
233.64M
26.28M
-80.80M
--
--
179.14M
179.14M
270.06M
FY 2016-12-31
52.82M
--
--
42.19M
--
--
0.00
--
2.74M
--
11.36M
--
109.11M
3.32M
--
--
--
39.74M
33.37M
--
28.78M
105.21M
214.32M
--
15.73M
0.00
--
--
--
--
--
23.55M
--
--
--
1.69M
40.97M
0.00
--
--
--
22.13M
22.13M
63.09M
16.00K
213.87M
-25.66M
-37.00M
--
--
151.23M
151.23M
214.32M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out EGRX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Eagle Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.